BERLIN -- For the first time in a phase III trial, adjuvant treatment with a CDK4/6 inhibitor significantly improved overall ...
Every time you do a Google Map search or use a self-driving car, you are using artificial intelligence.IBM's definition of ...
Demand for cultural commentary is higher than it’s ever been—but now that commentary is coming from unconventional new ...
Accounting technology is revolutionizing the way firms operate. What once took paper ledgers and hours of manual work can now be done in a fraction of … ...
SPDR NYSE Technology ETF is an alternative to XLK with an equal-weight approach, broader sector definition, and a tilt to ...
Positive results from the DESTINY-Breast05 Phase III trial showed ENHERTU ® (fam-trastuzumab deruxtecan-nxki) demonstrated a highly statistically significant and clinically meaningful improvement in ...